Center for Addiction Medicine


MGH Psychiatry Academy to Hold Substance Use Disorders Conference in February 2022

MGH Psychiatry Academy will hold a virtual Substance Use Disorders Conference from February 20 – February 23, 2022. The conference will discuss the latest research on a spectrum of substance use disorders and will provide guidance towards enhancing patient care. Sessions will cover topics including neuroscience, developmental perspectives, and recovery-oriented systems of care. To learn…MORE

SAMHSA Extends Methadone Take-Home Flexibility

The Substance Abuse and Mental Health Services Administration (SAMHSA) announced that it will extend methadone take-home flexibilities for one year once the COVID-19 Public Health Emergency expires. This will continue the take-home flexibilities that were instituted in March 2020 to reduce the risk of COVID-19 among patients and health care providers. SAMHSA noted that it is also considering…MORE

Dr. Eden Evins Wins NAMI Scientific Research Award

Dr. Eden Evins, Founding Director of MGH’s Center for Addiction Medicine and Harvard Medical School Professor of Psychiatry, has won the National Alliance on Mental Illness’s Scientific Research Award for her work on smoking cessation and reducing cardiovascular risk in people with serious mental illness. The Award was established in 2013 to recognize the work…MORE

CAM’s Grand Rounds Series Returns for Fall 2021

The Center for Addiction Medicine is excited to announce the return of its Grand Rounds series for Fall 2021, this time in a virtual format! We invite you to join us on Friday, October 8, from 11am-12pm via Zoom, for the first talk of our fall series. We will hear from guest speaker Mark Sullivan, PhD,…MORE

MGH Marks National Recovery Month with Events Raising Awareness

This September, Massachusetts General Hospital, led by the Substance Use Disorders Initiative, will mark National Recovery Month by hosting educational events to raise awareness of prevention, treatment, and recovery support services, and to celebrate the people who recover. The month kicks off with a virtual presentation on September 15 about harm reduction as a pathway to…MORE

Publication Alert: New Subgroup Analysis for the EAGLES Trial

Psychiatric Services recently published results from a post hoc analysis of CAM Director Dr. Eden Evins’s EAGLES (Evaluating Adverse Events in a Global Smoking Cessation Study) trial showing the efficacy of Varenicline in smokers with schizophrenia. The analysis found that Varenicline was more effective than placebo, Bupropion, or nicotine patch for smokers with schizophrenia. Additionally the odds…MORE

Dr. John Kelly Discusses Addiction and Brain Chemistry in Variety Magazine’s Recovery Issue

The Variety Magazine Recovery Issue, in its explanation of current addiction research, featured CAM Associate Director Dr. John Kelly to discuss how early substance use may impact brain chemistry development. The article, entitled “The Science of Addiction: How Substance Abuse Changes Brain Chemistry,” interviews addiction medicine researchers across the country to explore how biological, social…MORE

CAM Cannabis Intoxication Research Featured on Advances in Motion

Advances in Motion currently features the promising results of the Center for Addiction Medicine’s fNIRS study, with contributions from CAM Director Dr. Eden Evins and Director of Neuroscience Dr. Jodi Gilman. The article details important findings and future steps in assessing portable neuroimaging’s capacity to detect cannabis intoxication. To read the article, please visit:

CAM Poster Wins Two Awards at MGH Clinical Research Day

Co-first authors Rachel Plummer, Kelsey Lowman and Dr. Melissa Maravic received the Clinical and Outcome Research Award for their poster, “Behavioral Changes in Smokers from the PCORI Pragmatic Trial ‘Integrated Smoking Cessation Treatment for Smokers with Serious Mental Illness,’” at the 2019 Clinical Research Day. The poster also won a First Prize award from the…MORE

U.S. Surgeon General Issues Advisory On Impact of Marijuana Use

To emphasize the health risks of marijuana use in adolescence and during pregnancy, the U.S. Surgeon General recently issued a general warning explaining the drug’s harmful effects on the developing brain. The Surgeon General cited increased access to and potency of marijuana, along with misinformation about its safety, as contributing factors in the drug’s increasing…MORE